Hospital for Special Surgery - Archive (Lally)

2019
September
24,
2019
| 05:07 PM America/New_York
An international, multicenter phase II clinical trial is evaluating the efficacy and safety of mavrilimumab co-administered with a 26-week corticosteroid taper in patients with giant cell arteritis (GCA). The study is sponsored by Kiniksa Pharmaceuti...
Read more
June
10,
2019
| 11:00 PM America/New_York
CreakyJoints.org featuring Lindsay S. Lally, MD ...
Read more
2018
September
05,
2018
| 01:00 PM America/New_York
HealthCentral featured HSS rheumatologist Lindsay S. Lally, MD, in an article about managing complications from rheumatoid arthritis. She explained that physicians typically prefer to start treatment in patients early, but some medications could low...
Read more
Tags